First Manhattan’s bluebird bio BLUE Stock Holding History

First Manhattan’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-31	Closed	-$58K	–	1364
2018 Q3	$58K	Hold	31	–	–	﹤0.01%	950
2018 Q2	$62K	Hold	31	–	–	﹤0.01%	914
2018 Q1	$68K	Hold	31	–	–	﹤0.01%	882
2017 Q4	$71K	Hold	31	–	–	﹤0.01%	930
2017 Q3	$54K	Buy	+31	New	+$43.3K	﹤0.01%	935

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Manhattan's BLUE Position: Q4 2018 in Review

First Manhattan sold out of bluebird bio (BLUE) in Q4 2018, closing a stake of 31 shares — an estimated $58K sold.

First Manhattan first reported a position in BLUE in Q3 2017 and held it in 5 quarters. The position peaked at $71K in Q4 2017. 251 funds tracked by Wall St. Rank hold BLUE as of Q4 2018.

First Manhattan reported no remaining bluebird bio position as of Q4 2018 after selling out during the quarter.
First Manhattan sold 31 bluebird bio shares in Q4 2018, an estimated $58K.
First Manhattan first reported a position in bluebird bio in Q3 2017 and held it in 5 quarters.
First Manhattan's bluebird bio position peaked at $71K in Q4 2017.
251 funds tracked by Wall St. Rank held bluebird bio as of Q4 2018.

Based on First Manhattan's 13F filing for Q4 2018, filed 30 Jan 2019.